These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22376078)

  • 1. Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoate to paediatric patients.
    Suyagh M; Hawwa AF; Collier PS; Millership JS; Kole P; Millar M; Shields MD; Halliday HL; McElnay JC
    Br J Clin Pharmacol; 2012 Nov; 74(5):864-72. PubMed ID: 22376078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium canrenoate treatment in paediatric patients: a population pharmacokinetic study using novel dried blood spot sampling.
    Suyagh M; Hawwa AF; Collier PS; Millership JS; Kole P; Millar M; Shields MD; Halliday HL; McElnay JC
    J Hypertens; 2013 Sep; 31(9):1901-8. PubMed ID: 23846862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension Vista Digoxin Assay.
    Dasgupta A; Johnson MJ
    J Clin Lab Anal; 2010; 24(6):413-7. PubMed ID: 21089173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of potassium canreonate-canrenone in sinus rhythm restoration among patients with atrial fibrillation - a protocol of a pilot, randomized, double -blind, placebo-controlled study (CANREN-AF trial).
    Dąbrowski R; Syska P; Mączyńska J; Farkowski M; Sawicki S; Kubaszek-Kornatowska A; Michałek P; Kowalik I; Szwed H; Hryniewiecki T
    Trials; 2020 May; 21(1):397. PubMed ID: 32398047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy.
    Andriulli A; Arrigoni A; Gindro T; Karbowiak I; Buzzetti G; Armanini D
    Digestion; 1989; 44(3):155-62. PubMed ID: 2697627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative inotropic effects of aldosterone antagonists in isolated human and guinea-pig ventricular heart muscle.
    Mügge A; Schmitz W; Scholz H
    Klin Wochenschr; 1984 Aug; 62(15):717-23. PubMed ID: 6492693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically insignificant negative interferences of spironolactone, potassium canrenoate, and their common metabolite canrenone in new dimension vista LOCI digoxin immunoassay.
    Dasgupta A; Johnson MJ; Sengupta TK
    J Clin Lab Anal; 2012 May; 26(3):143-7. PubMed ID: 22628228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium.
    Berger C; Prieur C; Bochaton T; Berthiller J; Luyt CE; Bonnefoy-Cudraz E
    Arch Cardiovasc Dis; 2020 Nov; 113(11):679-689. PubMed ID: 32948466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution of 3H-canrenoate potassium in rabbits.
    Finn AM; Brown R; Sadée W
    J Pharm Sci; 1977 Feb; 66(2):275-7. PubMed ID: 839430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of canrenone after oral administration of spironolactone and intravenous injection of canrenoate-K in healthy man.
    Krause W; Karras J; Seifert W
    Eur J Clin Pharmacol; 1983; 25(4):449-53. PubMed ID: 6653638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible pharmacokinetic profiles of canrenoic acid and its biotransformed product. Canrenone in the rat.
    Asada S; Ohtawa T; Nakae H
    Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1012-8. PubMed ID: 2379271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
    Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
    Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantitative determination of butizide, potassium canrenoate and canrenone in tablets by high-performance liquid chromatography.
    De Croo F; Van den Bossche W; De Moerloose P
    J Chromatogr; 1986 Feb; 354():367-73. PubMed ID: 3700531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone and canrenoate-K: relative potency at steady state.
    Ramsay L; Asbury M; Shelton J; Harrison I
    Clin Pharmacol Ther; 1977 May; 21(5):602-9. PubMed ID: 858213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone and potassium canrenoate in normal man.
    Ramsay L; Shelton J; Harrison I; Tidd M; Asbury M
    Clin Pharmacol Ther; 1976 Aug; 20(2):167-77. PubMed ID: 780038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin.
    Dasgupta A; Saffer H; Wells A; Datta P
    J Clin Lab Anal; 2002; 16(4):172-7. PubMed ID: 12112389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients.
    Pettersen G; Mouksassi MS; Théorêt Y; Labbé L; Faure C; Nguyen B; Litalien C
    Br J Clin Pharmacol; 2009 Feb; 67(2):216-27. PubMed ID: 19173681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oral spironolactone in infants up to 2 years of age.
    Lass J; Leroux S; Kõrgvee LT; Varendi H; Kipper K; Takkis K; Aro R; Metsvaht T; Oselin K; Pfister M; Soeorg H; van den Anker J; Lutsar I
    Eur J Clin Pharmacol; 2024 Feb; 80(2):239-248. PubMed ID: 38041740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new turbidometric digoxin immunoassay on the ADVIA 1650 analyzer is free from interference by spironolactone, potassium canrenoate, and their common metabolite canrenone.
    Datta P; Dasgupta A
    Ther Drug Monit; 2003 Aug; 25(4):478-82. PubMed ID: 12883233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional beneficial effects of canrenoate in patients with anterior myocardial infarction on ACE-inhibitor treatment. A pilot study.
    Di Pasquale P; Cannizzaro S; Giubilato A; Vitrano MG; Scandurra A; Giambanco F; Saccone G; Sarullo FM; Paterna S
    Ital Heart J; 2001 Feb; 2(2):121-9. PubMed ID: 11256540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.